menu
    • menu

    Company profile for Signet

    NEW Drugs in Dev: 1
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 1986, Signet is a pioneer in the excipients business in India. Since its inception, Signet has combined technical expertise with commercial support to provide its clients accurate information and exceptional product value. With 105 qualified and well-trained members, the Signet team has an excellent understanding of the intricacies of the market and has strong relationships with key partners to take the company f...
    Founded in 1986, Signet is a pioneer in the excipients business in India. Since its inception, Signet has combined technical expertise with commercial support to provide its clients accurate information and exceptional product value. With 105 qualified and well-trained members, the Signet team has an excellent understanding of the intricacies of the market and has strong relationships with key partners to take the company forward. Today, the entire team's passion and commitment has made Signet an employer of choice for young talent.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Signetindia-flag Flag
    Country
    Country
    India
    Address
    Address
    A-801, Crescenzo C/38-39, G Block, Bandra Kurla Complex, Mumbai, Maharashtra 4...
    Telephone
    Telephone
    +91-22-61462725
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.signetexcipients.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    1st Targeted Therapy For Diffuse Gastric Cancer Gets FDA Fast Track
    1st Targeted Therapy For Diffuse Gastric Cancer Gets FDA Fast Track

    20 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250220670661/en

    BUSINESSWIRE
    20 Feb 2025
    Share Share
    Signet Gets FDA IND Approval For Targeted Diffuse Gastric Cancer Therapy
    Signet Gets FDA IND Approval For Targeted Diffuse Gastric Cancer Therapy

    01 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240701750486/en

    BUSINESSWIRE
    01 Jul 2024
    Share Share
    LAXAI Receives Investment from SIGNET Healthcare Partners
    LAXAI Receives Investment from SIGNET Healthcare Partners

    23 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221023005098/en/LAXAI-Receives-Investment-from-SIGNET-Healthcare-Partners

    BUSINESSWIRE
    23 Oct 2022
    Share Share
    Signet Healthcare Partners Completes Growth Equity Investment in Juno Pharma
    Signet Healthcare Partners Completes Growth Equity Investment in Juno Pharma

    24 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220224005368/en

    BUSINESSWIRE
    24 Feb 2022
    Share Share
    Signet Therapeutics gets a $10M top-up for next-gen cancer bets
    Signet Therapeutics gets a $10M top-up for next-gen cancer bets

    30 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211029005235/en/Empowering-Targeted-Cancer-Drug-Discovery-with-AI-and-Novel-Disease-Models-Signet-Therapeutics-Raises-10-million-in-Seed-2-Round

    BUSINESSWIRE
    30 Oct 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search